28.1 C
Delhi
Friday, September 19, 2025

France approves Omicron-adapted vaccines for booster shot

Date:

Share post:

Donate-GC-Razorpay

Paris: The French national health authority (HAS) approved three bivalent mRNA vaccines against the Covid-19 Omicron variants for a booster shot during the vaccination campaign starting on October 18.

According to the HAS on Tuesday, the three vaccines approved include those of Moderna and of Pfizer/BioNTech targetting the Omicron variant BA.1, and that of Pfizer/BioNTech adapted for the BA.4 and BA.5 Omicron subvariants.

“The HAS confirms its recommendation to administer an additional dose of the Covid-19 vaccine to people at risk of developing a severe form of the disease, as well as to their families and healthcare professionals in the autumn,” the HAS said in a statement.

The health authority said the bivalent mRNA vaccines are not new vaccines, but like the seasonal flu vaccines, they are updated to take into account the new form of virus circulating during the winter season.

The French Public Health Agency reported on Tuesday 51,816 new Covid-19 cases detected in the last 24 hours. A total of 79.1 per cent of the French population have received a full vaccination scheme.

Related articles

The Fractured Geopolitics of the Middle East: How Internal Divisions and External Interventions Are Degrading the Region

Introduction: A Region at War with ItselfThe Middle East and West Asia present a paradox of immense...

America’s $35 Trillion Debt: Crypto Cloud Scam to Reset the Dollar

In the corridors of geopolitical strategy, there are whispers louder than any official announcement, whispers that reveal not...

The American Military in Bangladesh: Quiet Landings, Loud Questions

The quiet arrival of American boots on Bangladeshi soil has raised eyebrows not just in Dhaka but in...

Qatar’s Blood Money: How Doha Bankrolled Hamas and Fueled the October 7 Massacre

 Since 2012, Qatar has positioned itself as Gaza’s saviour while quietly acting as its executioner. The numbers are...